Literature DB >> 21265059

IBD: Visilizumab not useful for intravenous steroid-refractory ulcerative colitis.

Natalie J Wood.   

Abstract

Entities:  

Year:  2011        PMID： 21265059     DOI： 10.1038/nrgastro.2010.205

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.

Authors:  William J Sandborn; Jean Frederic Colombel; Matthew Frankel; Daan Hommes; James N Lowder; Lloyd Mayer; Scott Plevy; Pieter Stokkers; Simon Travis; Gert Van Assche; Daniel C Baumgart; Stephan R Targan
Journal:  Gut       Date:  2010-11       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.